The Neoepitopes on Methylglyoxal- (MG-) Glycated Fibrinogen Generate Autoimmune Response: Its Role in Diabetes, Atherosclerosis, and Diabetic Atherosclerosis Subjects

Objectives. In diabetes mellitus, hyperglycemia-mediated nonenzymatic glycosylation of fibrinogen protein plays a crucial role in the pathogenesis of micro- and macrovascular complications especially atherosclerosis via the generation of advanced glycation end products (AGEs). Methylglyoxal (MG) ind...

Full description

Saved in:
Bibliographic Details
Published inOxidative medicine and cellular longevity Vol. 2021; no. 1; p. 6621568
Main Authors Rehman, Shahnawaz, Song, Jiantao, Faisal, Mohammad, Alatar, Abdulrahman A., Akhter, Firoz, Ahmad, Saheem, Hu, Bo
Format Journal Article
LanguageEnglish
Published United States Hindawi 2021
John Wiley & Sons, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objectives. In diabetes mellitus, hyperglycemia-mediated nonenzymatic glycosylation of fibrinogen protein plays a crucial role in the pathogenesis of micro- and macrovascular complications especially atherosclerosis via the generation of advanced glycation end products (AGEs). Methylglyoxal (MG) induces glycation of fibrinogen, resulting in structural alterations that lead to autoimmune response via the generation of neoepitopes on protein molecules. The present study was designed to probe the prevalence of autoantibodies against MG-glycated fibrinogen (MG-Fib) in type 2 diabetes mellitus (T2DM), atherosclerosis (ATH), and diabetic atherosclerosis (T2DM-ATH) patients. Design and Methods. The binding affinity of autoantibodies in patients’ sera (T2DM, n=100; ATH, n=100; and T2DM-ATH, n=100) and isolated immunoglobulin G (IgG) against native fibrinogen (N-Fib) and MG-Fib to healthy subjects (HS, n=50) was accessed by direct binding ELISA. The results of direct binding were further validated by competitive/inhibition ELISA. Moreover, AGE detection, ketoamines, protein carbonyls, hydroxymethylfurfural (HMF), thiobarbituric acid reactive substances (TBARS), and carboxymethyllysine (CML) concentrations in patients’ sera were also determined. Furthermore, free lysine and free arginine residues were also estimated. Results. The high binding affinity was observed in 54% of T2DM, 33% of ATH, and 65% of T2DM-ATH patients’ samples with respect to healthy subjects against MG-Fib antigen in comparison to N-Fib (p<0.05 to p<0.0001). HS sera showed nonsignificant binding (p>0.05) with N-Fib and MG-Fib. Other biochemical parameters were also found to be significant (p<0.05) in the patient groups with respect to the HS group. Conclusions. These findings in the future might pave a way to authenticate fibrinogen as a biomarker for the early detection of diabetes-associated micro- and macrovascular complications.
AbstractList Objectives . In diabetes mellitus, hyperglycemia‐mediated nonenzymatic glycosylation of fibrinogen protein plays a crucial role in the pathogenesis of micro‐ and macrovascular complications especially atherosclerosis via the generation of advanced glycation end products (AGEs). Methylglyoxal (MG) induces glycation of fibrinogen, resulting in structural alterations that lead to autoimmune response via the generation of neoepitopes on protein molecules. The present study was designed to probe the prevalence of autoantibodies against MG‐glycated fibrinogen (MG‐Fib) in type 2 diabetes mellitus (T2DM), atherosclerosis (ATH), and diabetic atherosclerosis (T2DM‐ATH) patients. Design and Methods . The binding affinity of autoantibodies in patients’ sera (T2DM, n = 100; ATH, n = 100; and T2DM‐ATH, n = 100) and isolated immunoglobulin G (IgG) against native fibrinogen (N‐Fib) and MG‐Fib to healthy subjects (HS, n = 50) was accessed by direct binding ELISA. The results of direct binding were further validated by competitive/inhibition ELISA. Moreover, AGE detection, ketoamines, protein carbonyls, hydroxymethylfurfural (HMF), thiobarbituric acid reactive substances (TBARS), and carboxymethyllysine (CML) concentrations in patients’ sera were also determined. Furthermore, free lysine and free arginine residues were also estimated. Results . The high binding affinity was observed in 54% of T2DM, 33% of ATH, and 65% of T2DM‐ATH patients’ samples with respect to healthy subjects against MG‐Fib antigen in comparison to N‐Fib ( p < 0.05 to p < 0.0001). HS sera showed nonsignificant binding ( p > 0.05) with N‐Fib and MG‐Fib. Other biochemical parameters were also found to be significant ( p < 0.05) in the patient groups with respect to the HS group. Conclusions . These findings in the future might pave a way to authenticate fibrinogen as a biomarker for the early detection of diabetes‐associated micro‐ and macrovascular complications.
In diabetes mellitus, hyperglycemia-mediated nonenzymatic glycosylation of fibrinogen protein plays a crucial role in the pathogenesis of micro- and macrovascular complications especially atherosclerosis via the generation of advanced glycation end products (AGEs). Methylglyoxal (MG) induces glycation of fibrinogen, resulting in structural alterations that lead to autoimmune response via the generation of neoepitopes on protein molecules. The present study was designed to probe the prevalence of autoantibodies against MG-glycated fibrinogen (MG-Fib) in type 2 diabetes mellitus (T2DM), atherosclerosis (ATH), and diabetic atherosclerosis (T2DM-ATH) patients. . The binding affinity of autoantibodies in patients' sera (T2DM, = 100; ATH, = 100; and T2DM-ATH, = 100) and isolated immunoglobulin G (IgG) against native fibrinogen (N-Fib) and MG-Fib to healthy subjects (HS, = 50) was accessed by direct binding ELISA. The results of direct binding were further validated by competitive/inhibition ELISA. Moreover, AGE detection, ketoamines, protein carbonyls, hydroxymethylfurfural (HMF), thiobarbituric acid reactive substances (TBARS), and carboxymethyllysine (CML) concentrations in patients' sera were also determined. Furthermore, free lysine and free arginine residues were also estimated. The high binding affinity was observed in 54% of T2DM, 33% of ATH, and 65% of T2DM-ATH patients' samples with respect to healthy subjects against MG-Fib antigen in comparison to N-Fib ( < 0.05 to < 0.0001). HS sera showed nonsignificant binding ( > 0.05) with N-Fib and MG-Fib. Other biochemical parameters were also found to be significant ( < 0.05) in the patient groups with respect to the HS group. These findings in the future might pave a way to authenticate fibrinogen as a biomarker for the early detection of diabetes-associated micro- and macrovascular complications.
In diabetes mellitus, hyperglycemia-mediated nonenzymatic glycosylation of fibrinogen protein plays a crucial role in the pathogenesis of micro- and macrovascular complications especially atherosclerosis via the generation of advanced glycation end products (AGEs). Methylglyoxal (MG) induces glycation of fibrinogen, resulting in structural alterations that lead to autoimmune response via the generation of neoepitopes on protein molecules. The present study was designed to probe the prevalence of autoantibodies against MG-glycated fibrinogen (MG-Fib) in type 2 diabetes mellitus (T2DM), atherosclerosis (ATH), and diabetic atherosclerosis (T2DM-ATH) patients. Design and Methods. The binding affinity of autoantibodies in patients' sera (T2DM, n = 100; ATH, n = 100; and T2DM-ATH, n = 100) and isolated immunoglobulin G (IgG) against native fibrinogen (N-Fib) and MG-Fib to healthy subjects (HS, n = 50) was accessed by direct binding ELISA. The results of direct binding were further validated by competitive/inhibition ELISA. Moreover, AGE detection, ketoamines, protein carbonyls, hydroxymethylfurfural (HMF), thiobarbituric acid reactive substances (TBARS), and carboxymethyllysine (CML) concentrations in patients' sera were also determined. Furthermore, free lysine and free arginine residues were also estimated.OBJECTIVESIn diabetes mellitus, hyperglycemia-mediated nonenzymatic glycosylation of fibrinogen protein plays a crucial role in the pathogenesis of micro- and macrovascular complications especially atherosclerosis via the generation of advanced glycation end products (AGEs). Methylglyoxal (MG) induces glycation of fibrinogen, resulting in structural alterations that lead to autoimmune response via the generation of neoepitopes on protein molecules. The present study was designed to probe the prevalence of autoantibodies against MG-glycated fibrinogen (MG-Fib) in type 2 diabetes mellitus (T2DM), atherosclerosis (ATH), and diabetic atherosclerosis (T2DM-ATH) patients. Design and Methods. The binding affinity of autoantibodies in patients' sera (T2DM, n = 100; ATH, n = 100; and T2DM-ATH, n = 100) and isolated immunoglobulin G (IgG) against native fibrinogen (N-Fib) and MG-Fib to healthy subjects (HS, n = 50) was accessed by direct binding ELISA. The results of direct binding were further validated by competitive/inhibition ELISA. Moreover, AGE detection, ketoamines, protein carbonyls, hydroxymethylfurfural (HMF), thiobarbituric acid reactive substances (TBARS), and carboxymethyllysine (CML) concentrations in patients' sera were also determined. Furthermore, free lysine and free arginine residues were also estimated.The high binding affinity was observed in 54% of T2DM, 33% of ATH, and 65% of T2DM-ATH patients' samples with respect to healthy subjects against MG-Fib antigen in comparison to N-Fib (p < 0.05 to p < 0.0001). HS sera showed nonsignificant binding (p > 0.05) with N-Fib and MG-Fib. Other biochemical parameters were also found to be significant (p < 0.05) in the patient groups with respect to the HS group.RESULTSThe high binding affinity was observed in 54% of T2DM, 33% of ATH, and 65% of T2DM-ATH patients' samples with respect to healthy subjects against MG-Fib antigen in comparison to N-Fib (p < 0.05 to p < 0.0001). HS sera showed nonsignificant binding (p > 0.05) with N-Fib and MG-Fib. Other biochemical parameters were also found to be significant (p < 0.05) in the patient groups with respect to the HS group.These findings in the future might pave a way to authenticate fibrinogen as a biomarker for the early detection of diabetes-associated micro- and macrovascular complications.CONCLUSIONSThese findings in the future might pave a way to authenticate fibrinogen as a biomarker for the early detection of diabetes-associated micro- and macrovascular complications.
Objectives. In diabetes mellitus, hyperglycemia-mediated nonenzymatic glycosylation of fibrinogen protein plays a crucial role in the pathogenesis of micro- and macrovascular complications especially atherosclerosis via the generation of advanced glycation end products (AGEs). Methylglyoxal (MG) induces glycation of fibrinogen, resulting in structural alterations that lead to autoimmune response via the generation of neoepitopes on protein molecules. The present study was designed to probe the prevalence of autoantibodies against MG-glycated fibrinogen (MG-Fib) in type 2 diabetes mellitus (T2DM), atherosclerosis (ATH), and diabetic atherosclerosis (T2DM-ATH) patients. Design and Methods. The binding affinity of autoantibodies in patients’ sera (T2DM, n=100; ATH, n=100; and T2DM-ATH, n=100) and isolated immunoglobulin G (IgG) against native fibrinogen (N-Fib) and MG-Fib to healthy subjects (HS, n=50) was accessed by direct binding ELISA. The results of direct binding were further validated by competitive/inhibition ELISA. Moreover, AGE detection, ketoamines, protein carbonyls, hydroxymethylfurfural (HMF), thiobarbituric acid reactive substances (TBARS), and carboxymethyllysine (CML) concentrations in patients’ sera were also determined. Furthermore, free lysine and free arginine residues were also estimated. Results. The high binding affinity was observed in 54% of T2DM, 33% of ATH, and 65% of T2DM-ATH patients’ samples with respect to healthy subjects against MG-Fib antigen in comparison to N-Fib (p<0.05 to p<0.0001). HS sera showed nonsignificant binding (p>0.05) with N-Fib and MG-Fib. Other biochemical parameters were also found to be significant (p<0.05) in the patient groups with respect to the HS group. Conclusions. These findings in the future might pave a way to authenticate fibrinogen as a biomarker for the early detection of diabetes-associated micro- and macrovascular complications.
Author Faisal, Mohammad
Akhter, Firoz
Rehman, Shahnawaz
Ahmad, Saheem
Alatar, Abdulrahman A.
Hu, Bo
Song, Jiantao
AuthorAffiliation 3 Department of Botany & Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
1 Department of Biochemistry, Sir Syed Faculty of Science, Mohammad Ali Jauhar University, Rampur, U.P., India
2 Department of Emergency, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China
4 Department of Biomedical Engineering, Stony Brook University, New York, USA
5 Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Hail, 2440, Saudi Arabia
AuthorAffiliation_xml – name: 2 Department of Emergency, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China
– name: 4 Department of Biomedical Engineering, Stony Brook University, New York, USA
– name: 5 Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Hail, 2440, Saudi Arabia
– name: 1 Department of Biochemistry, Sir Syed Faculty of Science, Mohammad Ali Jauhar University, Rampur, U.P., India
– name: 3 Department of Botany & Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
Author_xml – sequence: 1
  givenname: Shahnawaz
  orcidid: 0000-0002-3750-083X
  surname: Rehman
  fullname: Rehman, Shahnawaz
  organization: Department of BiochemistrySir Syed Faculty of ScienceMohammad Ali Jauhar UniversityRampurU.P.India
– sequence: 2
  givenname: Jiantao
  surname: Song
  fullname: Song, Jiantao
  organization: Department of EmergencyShandong Provincial Hospital Affiliated to Shandong First Medical UniversityJinanShandong 250021Chinasph.com.cn
– sequence: 3
  givenname: Mohammad
  orcidid: 0000-0002-8176-1527
  surname: Faisal
  fullname: Faisal, Mohammad
  organization: Department of Botany & MicrobiologyCollege of ScienceKing Saud UniversityP.O. Box 2455Riyadh 11451Saudi Arabiaksu.edu.sa
– sequence: 4
  givenname: Abdulrahman A.
  surname: Alatar
  fullname: Alatar, Abdulrahman A.
  organization: Department of Botany & MicrobiologyCollege of ScienceKing Saud UniversityP.O. Box 2455Riyadh 11451Saudi Arabiaksu.edu.sa
– sequence: 5
  givenname: Firoz
  orcidid: 0000-0002-8836-601X
  surname: Akhter
  fullname: Akhter, Firoz
  organization: Department of Biomedical EngineeringStony Brook UniversityNew YorkUSAstonybrook.edu
– sequence: 6
  givenname: Saheem
  orcidid: 0000-0003-1215-0279
  surname: Ahmad
  fullname: Ahmad, Saheem
  organization: Department of Medical Laboratory SciencesCollege of Applied Medical SciencesUniversity of Hail2440Saudi Arabiauoh.edu.sa
– sequence: 7
  givenname: Bo
  orcidid: 0000-0001-6049-9462
  surname: Hu
  fullname: Hu, Bo
  organization: Department of EmergencyShandong Provincial Hospital Affiliated to Shandong First Medical UniversityJinanShandong 250021Chinasph.com.cn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34970417$$D View this record in MEDLINE/PubMed
BookMark eNp9ksFu1DAQhi1URNuFG2dkiUsRDbWdxEk4IK0KXSq1IJVythxnsvHKsdPYAfaFeE687LaCleBiWzPf_PrHM8fowDoLCD2n5A2leX7GCKNnnDOa8_IROqJVxhJSVdnBw5uQQ3Ts_YoQnrKMPkGHaVYVJKPFEfp52wH-BA4GHdwAHjuLryF0a7M0a_dDmgSfXC-SV3hh1koGaPCFrkdt3RIsXoCFMQbxfApO9_1kAd-AH5z18BZfBo9vnAGsLX6vZQ0B_Cmehw5G55XZnDoGpG12aa32s_jLVK9ABf8UPW6l8fBsd8_Q14sPt-cfk6vPi8vz-VWisqwMScozKEAWqsw5MA5tKSXlbdXwsk65ampesKZRbUHyksmmlIpDQ7OUxvKiUmU6Q--2usNU99AosGGURgyj7uW4Fk5q8XfG6k4s3TdRFlEmZVHgZCcwursJfBC99gqMkRbc5AXjNK8YjUOJ6Ms9dOWm0cb2flMlpzwObIZe_Onowcr9CCPAtoCKX-ZHaIXSQQbtNga1EZSIzZ6IzZ6I3Z7EotO9onvdf-Cvt3inbSO_6__TvwCEa80G
CitedBy_id crossref_primary_10_1016_j_abb_2024_109911
crossref_primary_10_1002_cbf_3722
crossref_primary_10_1016_j_cca_2023_117684
crossref_primary_10_3389_fendo_2024_1371682
crossref_primary_10_1016_j_ijbiomac_2022_02_093
crossref_primary_10_1186_s40001_024_01739_1
Cites_doi 10.2174/1570161115666170327162639
10.1007/s10741-013-9374-y
10.1177/000456329102800613
10.1016/0003-2697(79)90738-3
10.1042/bj2910529
10.3906/biy-1501-71
10.1016/j.diabres.2018.04.025
10.1002/jcb.26146
10.1007/s00059-004-2607-z
10.1182/blood-2006-08-040956
10.1016/0014-5793(88)80066-8
10.1002/jcla.22039
10.5507/bp.2011.013
10.2337/diabetes.54.6.1615
10.1016/j.ijbiomac.2021.01.197
10.1016/j.thromres.2006.10.016
10.1016/S0891-5849(02)00780-3
10.1016/j.diabres.2004.09.004
10.1042/BST20140009
10.1002/jcb.27170
10.1016/j.abb.2018.02.019
10.3109/08916934.2014.941059
10.1007/s00125-005-1742-2
10.1042/BCJ20160503C
10.1016/0003-2697(69)90032-3
10.1016/j.ijbiomac.2018.04.016
10.3389/fchem.2017.00039
10.1007/s12013-014-9991-7
10.1155/2011/718694
10.1016/0002-9149(93)90142-Y
10.1016/j.jdiacomp.2015.12.018
10.1016/j.lfs.2016.02.013
10.1016/j.ijbiomac.2014.10.034
10.1093/glycob/cwu057
10.2337/diab.32.7.680
10.1016/j.metabol.2009.09.010
10.1093/clinchem/44.3.522
10.1021/ac0514220
10.1016/j.semcancer.2017.10.005
10.1155/2014/417842
10.3390/ijms18050984
10.1007/s11010-019-03550-7
10.1155/2017/1209676
10.1152/ajpendo.00535.2001
10.1007/s12013-015-0713-6
10.1016/j.bbrc.2011.03.064
10.1006/bbrc.1997.7718
10.2169/internalmedicine.38.309
10.1093/oxfordjournals.jbchem.a022062
10.1371/journal.pone.0053205
10.1016/0009-8981(83)90078-5
10.1016/S0076-6879(94)33040-9
10.1016/j.cbi.2014.06.012
10.1016/j.ijbiomac.2013.08.037
10.1210/er.2018-00141
10.1042/bj20030763
10.1016/j.biopha.2017.10.122
10.1042/BST20140018
10.1007/s11010-010-0541-3
10.1042/bj3440109
10.1007/s12013-011-9335-9
10.1016/j.semcancer.2017.07.001
10.1016/j.jcte.2014.05.002
10.2741/s474
10.1371/journal.pone.0191014
10.1016/S0009-8981(03)00003-2
10.1093/glycob/cwz012
10.3109/10715768809066899
10.1016/j.cellimm.2020.104062
10.1152/ajpendo.00274.2003
10.1002/9783527633500
ContentType Journal Article
Copyright Copyright © 2021 Shahnawaz Rehman et al.
Copyright © 2021 Shahnawaz Rehman et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0
Copyright © 2021 Shahnawaz Rehman et al. 2021
Copyright_xml – notice: Copyright © 2021 Shahnawaz Rehman et al.
– notice: Copyright © 2021 Shahnawaz Rehman et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0
– notice: Copyright © 2021 Shahnawaz Rehman et al. 2021
DBID RHU
RHW
RHX
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
M0S
M1P
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
Q9U
7X8
5PM
DOI 10.1155/2021/6621568
DatabaseName Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic
ProQuest Publicly Available Content
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic
Publicly Available Content Database

Database_xml – sequence: 1
  dbid: RHX
  name: Hindawi Publishing Open Access
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1942-0994
Editor Ghose, Jayeeta
Editor_xml – sequence: 1
  givenname: Jayeeta
  surname: Ghose
  fullname: Ghose, Jayeeta
ExternalDocumentID PMC8714332
34970417
10_1155_2021_6621568
Genre Journal Article
GeographicLocations United Kingdom--UK
India
GeographicLocations_xml – name: United Kingdom--UK
– name: India
GrantInformation_xml – fundername: Outstanding Innovation Team Promotion Plan of Shandong Provincial Hospital Affiliated to Shandong First Medical University
– fundername: King Saud University
  grantid: RSP-2021/86
GroupedDBID ---
3V.
4.4
53G
5VS
7X7
88E
8FI
8FJ
8G5
AAFWJ
AAJEY
ABUWG
ADBBV
ADRAZ
AENEX
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
DIK
DWQXO
E3Z
EBD
EBS
EMOBN
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
HMCUK
HYE
IAO
IEA
IHR
INH
INR
ITC
KQ8
M1P
M2O
M48
M~E
O5R
O5S
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RHU
RHW
RHX
RNS
RPM
SV3
TR2
UKHRP
0R~
24P
AAYXX
ACCMX
ALIPV
CITATION
EJD
H13
IPNFZ
PGMZT
PHGZM
PHGZT
RIG
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
7XB
8FK
K9.
MBDVC
PKEHL
PQEST
PQUKI
Q9U
7X8
5PM
ID FETCH-LOGICAL-c448t-364e7ea7c856e26ef8aa16f9d68b36cdb672ddcf70582ad8ac6ed1431c4479c83
IEDL.DBID M48
ISSN 1942-0900
1942-0994
IngestDate Thu Aug 21 18:34:09 EDT 2025
Fri Jul 11 07:41:53 EDT 2025
Fri Jul 25 20:51:16 EDT 2025
Mon Jul 21 06:06:02 EDT 2025
Thu Apr 24 22:57:57 EDT 2025
Tue Jul 01 02:52:42 EDT 2025
Sun Jun 02 18:54:52 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © 2021 Shahnawaz Rehman et al.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c448t-364e7ea7c856e26ef8aa16f9d68b36cdb672ddcf70582ad8ac6ed1431c4479c83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Academic Editor: Jayeeta Ghose
ORCID 0000-0002-8176-1527
0000-0002-8836-601X
0000-0002-3750-083X
0000-0003-1215-0279
0000-0001-6049-9462
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1155/2021/6621568
PMID 34970417
PQID 2615861606
PQPubID 2037493
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8714332
proquest_miscellaneous_2615921090
proquest_journals_2615861606
pubmed_primary_34970417
crossref_citationtrail_10_1155_2021_6621568
crossref_primary_10_1155_2021_6621568
hindawi_primary_10_1155_2021_6621568
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-00-00
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – year: 2021
  text: 2021-00-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New York
PublicationTitle Oxidative medicine and cellular longevity
PublicationTitleAlternate Oxid Med Cell Longev
PublicationYear 2021
Publisher Hindawi
John Wiley & Sons, Inc
Publisher_xml – name: Hindawi
– name: John Wiley & Sons, Inc
References e_1_2_11_70_2
e_1_2_11_30_2
e_1_2_11_55_2
e_1_2_11_76_2
e_1_2_11_57_2
e_1_2_11_13_2
La Cote A. L. C. (e_1_2_11_27_2) 2011
e_1_2_11_34_2
e_1_2_11_51_2
e_1_2_11_72_2
e_1_2_11_11_2
e_1_2_11_32_2
e_1_2_11_53_2
e_1_2_11_74_2
e_1_2_11_6_2
e_1_2_11_4_2
e_1_2_11_25_2
e_1_2_11_2_2
e_1_2_11_48_2
e_1_2_11_69_2
e_1_2_11_29_2
e_1_2_11_60_2
Hatton M. W. (e_1_2_11_24_2) 1993; 121
e_1_2_11_20_2
e_1_2_11_43_2
e_1_2_11_66_2
e_1_2_11_45_2
e_1_2_11_68_2
e_1_2_11_62_2
e_1_2_11_8_2
e_1_2_11_22_2
e_1_2_11_41_2
e_1_2_11_64_2
e_1_2_11_17_2
e_1_2_11_15_2
e_1_2_11_36_2
Rehman S. (e_1_2_11_38_2) 2019; 20
e_1_2_11_59_2
e_1_2_11_19_2
e_1_2_11_71_2
e_1_2_11_31_2
e_1_2_11_54_2
e_1_2_11_56_2
e_1_2_11_35_2
e_1_2_11_50_2
e_1_2_11_12_2
e_1_2_11_33_2
e_1_2_11_52_2
e_1_2_11_75_2
e_1_2_11_10_2
e_1_2_11_28_2
e_1_2_11_5_2
e_1_2_11_26_2
e_1_2_11_3_2
e_1_2_11_47_2
e_1_2_11_1_2
e_1_2_11_49_2
Ahmad R. (e_1_2_11_73_2) 2008; 22
e_1_2_11_44_2
e_1_2_11_65_2
e_1_2_11_46_2
e_1_2_11_67_2
e_1_2_11_9_2
e_1_2_11_23_2
e_1_2_11_40_2
e_1_2_11_61_2
e_1_2_11_7_2
e_1_2_11_21_2
e_1_2_11_42_2
e_1_2_11_63_2
e_1_2_11_16_2
e_1_2_11_14_2
e_1_2_11_58_2
e_1_2_11_37_2
e_1_2_11_18_2
e_1_2_11_39_2
References_xml – ident: e_1_2_11_4_2
  doi: 10.2174/1570161115666170327162639
– ident: e_1_2_11_2_2
  doi: 10.1007/s10741-013-9374-y
– ident: e_1_2_11_29_2
  doi: 10.1177/000456329102800613
– ident: e_1_2_11_56_2
  doi: 10.1016/0003-2697(79)90738-3
– ident: e_1_2_11_67_2
  doi: 10.1042/bj2910529
– ident: e_1_2_11_3_2
  doi: 10.3906/biy-1501-71
– ident: e_1_2_11_20_2
  doi: 10.1016/j.diabres.2018.04.025
– start-page: 75
  volume-title: Advances in protein chemistry and structural biology
  year: 2011
  ident: e_1_2_11_27_2
– ident: e_1_2_11_37_2
  doi: 10.1002/jcb.26146
– volume: 121
  start-page: 588
  year: 1993
  ident: e_1_2_11_24_2
  article-title: Catabolism of unglycated and naturally glycated forms of rabbit fibrinogen: their interaction with the healthy and deendothelialized aorta wall in normal and diabetic rabbits
  publication-title: The Journal of Laboratory and Clinical Medicine
– ident: e_1_2_11_25_2
  doi: 10.1007/s00059-004-2607-z
– ident: e_1_2_11_19_2
  doi: 10.1182/blood-2006-08-040956
– ident: e_1_2_11_62_2
  doi: 10.1016/0014-5793(88)80066-8
– ident: e_1_2_11_42_2
  doi: 10.1002/jcla.22039
– ident: e_1_2_11_72_2
  doi: 10.5507/bp.2011.013
– ident: e_1_2_11_1_2
  doi: 10.2337/diabetes.54.6.1615
– ident: e_1_2_11_76_2
  doi: 10.1016/j.ijbiomac.2021.01.197
– ident: e_1_2_11_21_2
  doi: 10.1016/j.thromres.2006.10.016
– ident: e_1_2_11_68_2
  doi: 10.1016/S0891-5849(02)00780-3
– ident: e_1_2_11_75_2
  doi: 10.1016/j.diabres.2004.09.004
– ident: e_1_2_11_13_2
  doi: 10.1042/BST20140009
– ident: e_1_2_11_60_2
  doi: 10.1002/jcb.27170
– ident: e_1_2_11_65_2
  doi: 10.1016/j.abb.2018.02.019
– ident: e_1_2_11_46_2
  doi: 10.3109/08916934.2014.941059
– ident: e_1_2_11_26_2
  doi: 10.1007/s00125-005-1742-2
– ident: e_1_2_11_7_2
  doi: 10.1042/BCJ20160503C
– ident: e_1_2_11_57_2
  doi: 10.1016/0003-2697(69)90032-3
– ident: e_1_2_11_59_2
  doi: 10.1016/j.ijbiomac.2018.04.016
– ident: e_1_2_11_32_2
– ident: e_1_2_11_15_2
  doi: 10.3389/fchem.2017.00039
– ident: e_1_2_11_50_2
  doi: 10.1007/s12013-014-9991-7
– ident: e_1_2_11_58_2
  doi: 10.1155/2011/718694
– ident: e_1_2_11_16_2
  doi: 10.1016/0002-9149(93)90142-Y
– ident: e_1_2_11_22_2
  doi: 10.1016/j.jdiacomp.2015.12.018
– ident: e_1_2_11_41_2
  doi: 10.1016/j.lfs.2016.02.013
– ident: e_1_2_11_40_2
  doi: 10.1016/j.ijbiomac.2014.10.034
– ident: e_1_2_11_17_2
  doi: 10.1093/glycob/cwu057
– volume: 20
  start-page: 1
  year: 2019
  ident: e_1_2_11_38_2
  article-title: Physico-chemical changes induced in serum proteins, immunoglobulin-G and fibrinogen by reactive carbonyl species, methylglyoxal
  publication-title: Current Protein & Peptide Science
– ident: e_1_2_11_30_2
  doi: 10.2337/diab.32.7.680
– ident: e_1_2_11_51_2
  doi: 10.1016/j.metabol.2009.09.010
– ident: e_1_2_11_63_2
  doi: 10.1093/clinchem/44.3.522
– ident: e_1_2_11_70_2
  doi: 10.1021/ac0514220
– volume: 22
  start-page: 525
  year: 2008
  ident: e_1_2_11_73_2
  article-title: Malondialdehyde and protein carbonyl as biomarkers for oxidative stress and disease progression in patients with chronic myeloid leukemia
  publication-title: in vivo
– ident: e_1_2_11_6_2
  doi: 10.1016/j.semcancer.2017.10.005
– ident: e_1_2_11_9_2
  doi: 10.1155/2014/417842
– ident: e_1_2_11_10_2
  doi: 10.3390/ijms18050984
– ident: e_1_2_11_8_2
  doi: 10.1007/s11010-019-03550-7
– ident: e_1_2_11_28_2
  doi: 10.1155/2017/1209676
– ident: e_1_2_11_34_2
  doi: 10.1152/ajpendo.00535.2001
– ident: e_1_2_11_52_2
  doi: 10.1007/s12013-015-0713-6
– ident: e_1_2_11_45_2
  doi: 10.1016/j.bbrc.2011.03.064
– ident: e_1_2_11_31_2
  doi: 10.1006/bbrc.1997.7718
– ident: e_1_2_11_71_2
  doi: 10.2169/internalmedicine.38.309
– ident: e_1_2_11_35_2
  doi: 10.1093/oxfordjournals.jbchem.a022062
– ident: e_1_2_11_48_2
  doi: 10.1371/journal.pone.0053205
– ident: e_1_2_11_49_2
  doi: 10.1016/0009-8981(83)90078-5
– ident: e_1_2_11_53_2
  doi: 10.1016/S0076-6879(94)33040-9
– ident: e_1_2_11_47_2
  doi: 10.1016/j.cbi.2014.06.012
– ident: e_1_2_11_55_2
  doi: 10.1016/j.ijbiomac.2013.08.037
– ident: e_1_2_11_23_2
  doi: 10.1210/er.2018-00141
– ident: e_1_2_11_74_2
  doi: 10.1042/bj20030763
– ident: e_1_2_11_36_2
  doi: 10.1016/j.biopha.2017.10.122
– ident: e_1_2_11_14_2
  doi: 10.1042/BST20140018
– ident: e_1_2_11_5_2
  doi: 10.1007/s11010-010-0541-3
– ident: e_1_2_11_11_2
  doi: 10.1042/bj3440109
– ident: e_1_2_11_64_2
  doi: 10.1007/s12013-011-9335-9
– ident: e_1_2_11_18_2
  doi: 10.1016/j.semcancer.2017.07.001
– ident: e_1_2_11_39_2
  doi: 10.1016/j.jcte.2014.05.002
– ident: e_1_2_11_12_2
  doi: 10.2741/s474
– ident: e_1_2_11_54_2
  doi: 10.1371/journal.pone.0191014
– ident: e_1_2_11_69_2
  doi: 10.1016/S0009-8981(03)00003-2
– ident: e_1_2_11_43_2
  doi: 10.1093/glycob/cwz012
– ident: e_1_2_11_61_2
  doi: 10.3109/10715768809066899
– ident: e_1_2_11_44_2
  doi: 10.1016/j.cellimm.2020.104062
– ident: e_1_2_11_33_2
  doi: 10.1152/ajpendo.00274.2003
– ident: e_1_2_11_66_2
  doi: 10.1002/9783527633500
SSID ssj0063241
Score 2.2808392
Snippet Objectives. In diabetes mellitus, hyperglycemia-mediated nonenzymatic glycosylation of fibrinogen protein plays a crucial role in the pathogenesis of micro-...
Objectives . In diabetes mellitus, hyperglycemia‐mediated nonenzymatic glycosylation of fibrinogen protein plays a crucial role in the pathogenesis of micro‐...
In diabetes mellitus, hyperglycemia-mediated nonenzymatic glycosylation of fibrinogen protein plays a crucial role in the pathogenesis of micro- and...
SourceID pubmedcentral
proquest
pubmed
crossref
hindawi
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 6621568
SubjectTerms Adult
Atherosclerosis
Atherosclerosis - physiopathology
Diabetes
Diabetes Mellitus, Type 2 - physiopathology
Female
Fibrinogen - metabolism
Glucose
Humans
Hyperglycemia
Male
Middle Aged
Oxidative stress
Peptides
Proteins
Pyruvaldehyde - metabolism
Sodium
SummonAdditionalLinks – databaseName: Hindawi Publishing Open Access
  dbid: RHX
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9NAEF-8gwNfxG_jnbLCCYoGm2z2I74VsVeF3sPhQd_CZnfqBcKmmJTz_iH_TmeatNiq6EsgmQlZMjM785udnWXsVCeJlQRy0lKUCFCsiQ3oUZyh9xG5AgBFG4Vn52p6mX2ey_nQJKn9fQkfvR3B8-SdUuiblDlgB6hgBMqn882ESw3H17gqz1JKO4w29e177-54nqMrgrzX1Z8Cy_36yF8czuQuuzNEinzci_YeuwXhPjvqz468ecB-oID5OTSwRJtcQsubwGeAv73-Wt80320d81ezs_g1P6spRwOeT6i6PzSoMbxvNt0BH6-6pqItIsAv-mpZeM8_dS2_aGrgVeBDxUz7lo8pVGxaHAteK3xggx_IlduncpyQKMPTPmSXk49fPkzj4dCF2CFS62KhMtBgtTNSQapgYaxN1CL3ypRCOV8qnXrvFnokTWq9sU6Bx6Arwdd17ox4xA5DE-AJ46XxGkrjfKLLTC5EboXCAE0riXBe-jJibzYCKdzQkZwOxqiLNTKRsiDxFYP4IvZyy73sO3H8he90kO0_2E42gi8Gs20LhJPSqARBXcRebMlocLSKYgM0q54nT6meNWKPez3ZfkhkuR5liY6Y3tGgLQM1896lhOpq3dTb0EH0In36f6M_Zrfpts8FnbDD7tsKnmF01JXP17bxEyefCQg
  priority: 102
  providerName: Hindawi Publishing
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3da9RAEF-0UvBF_DZaZYUKioZePvYjvsghXqtwfSgW7i1sdudsIGRPk0P7D_l3OpPsnW3x4yUPmQlJmJmd-c3OzjC2r5LECAI5aZVVCFCMjjWoSZyj98kKCQCSDgrPj-XRaf5pIRYh4daFssrNmjgs1M5bypEfYKQvtEww3n63-hrT1CjaXQ0jNK6zG9S6jEq61GILuKgT-QC4ijylfMRkU_guBGH-5EBKdHjUZPWCS9o9Iyz8vf5TxHm1cPKCJ5rdZrdCCMmno8zvsGvQ3mW741DJ83vsJ0qeH4OHFRrrCjruWz4HlEfzpTn3P0wT85fzw_gVP2woeQOOz6jsv_WoSnzsQt0Dn657X9PZEeAnYxktvOUf-46f-AZ43fJQStO94VOKIX2H34LXGm-Y1gVyba9SOa5UlPrp7rPT2YfP74_iMI0htgjh-jiTOSgwymohIZWw1MYkclk4qatMWldJlTpnl2oidGqcNlaCw2gswcdVYXX2gO20voVHjFfaKai0dYmqcrHMCpNJjNyUFIjzhasi9nojkNKGVuU0MaMpB8giREniK4P4IvZiy70aW3T8hW8_yPY_bHsbwZfBnrvyt_ZF7PmWjJZI2yumBb8eeYqUCl0j9nDUk-2LsrxQkzxREVOXNGjLQF2-L1Pa-mzo9q1pQn2WPv73Zz1hN-knxuTQHtvpv63hKYZLffVssIlfSxkTSg
  priority: 102
  providerName: ProQuest
Title The Neoepitopes on Methylglyoxal- (MG-) Glycated Fibrinogen Generate Autoimmune Response: Its Role in Diabetes, Atherosclerosis, and Diabetic Atherosclerosis Subjects
URI https://dx.doi.org/10.1155/2021/6621568
https://www.ncbi.nlm.nih.gov/pubmed/34970417
https://www.proquest.com/docview/2615861606
https://www.proquest.com/docview/2615921090
https://pubmed.ncbi.nlm.nih.gov/PMC8714332
Volume 2021
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ri9NAEB_uwcl9Ed9Wz7LCCYpGm8c-IohUuV4VWqR40G9hk516gZDUS4rXf8i_09k8qldOBL_sh-wsecxMZn6zszMAx9J1Nbcgx4v9mACKVo5COXACsj5-KBBR2IPCk6kYnwWf53y-A1230fYDltdCO9tP6uwie335ff2eFP5drfCcW_zuvhGCjJdQu7BPNklaFZ0Em_0EW5O8hl5h4NnIxKBLgd9afQg3_CCUg6DuX_bbTh2cW4D8I73ODd3OpvzDPI1uwc3Wr2TDRhBuww7md-Cg6TS5vgs_SRzYFAtckgYvsWRFziZITMq-ZeviUmcOez45dV6w08xGdNCwkT0LkBckX6wpTV0hG66qIrUHSpDNmtxafMs-VSWbFRmyNGdtfk35ig2tY1mU9Cw0pnRB56adTpPtWUa_LxsPKu_B2ejk68ex07ZocBLCdZXjiwAlapkoLtATuFBau2IRGqFiXyQmFtIzJlnIAVeeNkonAg25aC4tl2Gi_Puwlxc5PgQWKyMxVolxZRzwhR9qX5A7JwUn8M9N3IOXHUOipK1fbttoZFGNYziPLCejlpM9eLahXjZ1O_5Cd9zy9h9kRx3jo05GIwKfXAmXIGAPnm6mST3tnovOsVg1NKFns1978KCRk82NOlHrgbwiQRsCW_r76kyentclwJVtW-97j_575WM4tO_XBJOOYK-6WOETcq-quA-7ci77sP_hZPpl1q_1iMbZeP4LSA4l7Q
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVBVcEG8MBRaplUDUavzYh5EQCtA0oU2EolbqzdjeCbVk2QE7KvlDHPmNzMR2aCsep1588I7ttWZ2dr7ZeTC2pRwnEgRy3NiLEaBE2taguraPu48XSACQlCg8GsvBsf_xRJyssZ9tLgyFVbY6camoTZGQj3wXLX2hpYP29tvZV5u6RtHpattCoxaLA1icIWQr3ww_IH-3Xbe_d_R-YDddBewEoUhle9IHBZFKtJDgSpjqKHLkNDBSx55MTCyVa0wyVV2h3cjoKJFg0Kpw8HEVJNrD915j676HUKbD1t_tjT9NWt1Ptc-XEC_wXfKAdNtQeyHIy-DsSolbLJV1PbcJbpwS-j5L_2TjXg7VPLf39W-xm43Rynu1lN1ma5DfYRt1G8vFXfYDZY2PoYAZqocZlLzI-QhQArIv2aL4HmU2fzHat1_y_YzcRWB4nxIN8gKFl9d1ryvgvXlVpJStAnxSB-7Caz6sSj4pMuBpzpvgnXKH98hqLUqcC15TvBHlphlOk8ujHHUjOZvKe-z4Sjh1n3XyIoeHjMfaKIh1YhwV-2LqBZEn0VZUUkDsChNb7FXLkDBpiqNTj44sXIIkIUJiX9iwz2LbK-pZXRTkL3RbDW__Q7bZMj5sNEgZ_pZ3iz1fDePapwOdKIdiXtMELoXWWuxBLSerD3l-oLq-oyymLkjQioDqil8cydPTZX1xxNBU1e7Rv6f1jF0fHI0Ow8Ph-OAxu0E_VLumNlmn-jaHJ2isVfHTZoVw9vmqF-UvqMxSqw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9NAEF6VoiJeEDcpBRaplUDUSnzsYSSEIkraUBKhikp5M2vvpLVk2QE7KvlD_Ah-HTOxHdqK46kvfvCO7bVmdna-2TkY21auawSBHC_2YwQoRjsaVM8JcPfxQwkAkhKFR2N5cBx8mIjJGvvZ5sJQWGWrE5eK2hYJ-ci7aOkLLV20t7vTJizi097g7eyrQx2k6KS1badRi8ghLM4QvpVvhnvI6x3PG7z__O7AaToMOAnCksrxZQAKjEq0kOBJmGpjXDkNrdSxLxMbS-VZm0xVT2jPWG0SCRYtDBcfV2GifXzvNXZd-cKlNaYmK7BHVdCXYC8MPPKF9NqgeyHI3-B2pcTNlgq8ntsON04Jh5-lf7J2LwdtntsFB7fZrcZ85f1a3u6wNcjvso26oeXiHvuBUsfHUMAMFcUMSl7kfAQoC9lJtii-m8zhL0b7zku-n5HjCCwfUMpBXqAY87oCdgW8P6-KlPJWgB_VIbzwmg-rkh8VGfA0500YT7nL-2S_FiXOBa8p3jC5bYbT5PIoRy1JbqfyPju-Ej49YOt5kcMjxmNtFcQ6sa6KAzH1Q-NLtBqVFBB7wsYd9qplSJQ0ZdKpW0cWLeGSEBGxL2rY12E7K-pZXR7kL3TbDW__Q7bVMj5qdEkZ_Zb8Dnu-GkYtQEc7JodiXtOEHgXZdtjDWk5WH_KDUPUCV3WYuiBBKwKqMH5xJE9Pl5XGEU1TfbvNf0_rGbuBSzH6OBwfPmY36X9qH9UWW6--zeEJWm1V_HS5PDj7ctXr8ReYd1V7
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Neoepitopes+on+Methylglyoxal-+%28MG-%29+Glycated+Fibrinogen+Generate+Autoimmune+Response%3A+Its+Role+in+Diabetes%2C+Atherosclerosis%2C+and+Diabetic+Atherosclerosis+Subjects&rft.jtitle=Oxidative+medicine+and+cellular+longevity&rft.au=Rehman%2C+Shahnawaz&rft.au=Song%2C+Jiantao&rft.au=Faisal%2C+Mohammad&rft.au=Alatar%2C+Abdulrahman+A.&rft.date=2021&rft.pub=Hindawi&rft.issn=1942-0900&rft.eissn=1942-0994&rft.volume=2021&rft_id=info:doi/10.1155%2F2021%2F6621568&rft_id=info%3Apmid%2F34970417&rft.externalDocID=PMC8714332
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1942-0900&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1942-0900&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1942-0900&client=summon